As of 2025-07-20, the EV/EBITDA ratio of Repro Med Systems Inc (KRMD) is -30.64. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. KRMD's latest enterprise value is 147.18 mil USD. KRMD's TTM EBITDA according to its financial statements is -4.80 mil USD. Dividing these 2 quantities gives us the above KRMD EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 15.4x - 19.5x | 16.8x |
| Forward P/E multiples | 16.0x - 22.2x | 19.6x |
| Fair Price | (1.49) - (1.85) | (1.71) |
| Upside | -144.1% - -154.8% | -150.9% |
| Date | EV/EBITDA |
| 2025-06-26 | -32.66 |
| 2025-06-25 | -31.03 |
| 2025-06-24 | -32.47 |
| 2025-06-23 | -31.22 |
| 2025-06-20 | -30.74 |
| 2025-06-18 | -29.49 |
| 2025-06-17 | -29.49 |
| 2025-06-16 | -29.30 |
| 2025-06-13 | -29.30 |
| 2025-06-12 | -29.01 |
| 2025-06-11 | -29.01 |
| 2025-06-10 | -29.01 |
| 2025-06-09 | -27.28 |
| 2025-06-06 | -27.86 |
| 2025-06-05 | -26.32 |
| 2025-06-04 | -25.36 |
| 2025-06-03 | -25.55 |
| 2025-06-02 | -25.07 |
| 2025-05-30 | -24.21 |
| 2025-05-29 | -25.74 |
| 2025-05-28 | -26.42 |
| 2025-05-27 | -26.22 |
| 2025-05-23 | -23.82 |
| 2025-05-22 | -24.40 |
| 2025-05-21 | -25.17 |
| 2025-05-20 | -26.61 |
| 2025-05-19 | -26.80 |
| 2025-05-16 | -26.61 |
| 2025-05-15 | -27.67 |
| 2025-05-14 | -27.19 |
| 2025-05-13 | -29.11 |
| 2025-05-12 | -29.49 |
| 2025-05-09 | -28.53 |
| 2025-05-08 | -29.88 |
| 2025-05-07 | -24.40 |
| 2025-05-06 | -24.59 |
| 2025-05-05 | -24.78 |
| 2025-05-02 | -25.65 |
| 2025-05-01 | -24.69 |
| 2025-04-30 | -24.69 |
| 2025-04-29 | -23.44 |
| 2025-04-28 | -23.82 |
| 2025-04-25 | -22.00 |
| 2025-04-24 | -22.19 |
| 2025-04-23 | -21.52 |
| 2025-04-22 | -21.52 |
| 2025-04-21 | -19.79 |
| 2025-04-17 | -20.08 |
| 2025-04-16 | -20.27 |
| 2025-04-15 | -21.33 |